Filana Therapeutics, Inc. (FLNA) — Net Asset Quality Index
Filana Therapeutics, Inc. (FLNA) has a Net Asset Quality Index of 61.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $103.90 Million minus total liabilities of $40.29 Million yields net assets of $63.61 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read Filana Therapeutics, Inc. balance sheet liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Filana Therapeutics, Inc. Net Asset Quality Index Over Time (2022–2025)
This chart shows how Filana Therapeutics, Inc.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of June 2026, the index stands at 61.2%, representing net assets of $63.61 Million against total assets of $103.90 Million USD. For live market cap and overall valuation, see Filana Therapeutics, Inc. market capitalisation.
Annual Net Asset Quality Index for Filana Therapeutics, Inc. (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Filana Therapeutics, Inc. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Filana Therapeutics, Inc. (FLNA) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 62.9% | $74.40 Million | $118.36 Million | $43.95 Million | ▼ -29.6 pp |
| 2024 | 92.5% | $145.70 Million | $157.53 Million | $11.83 Million | ▲ +1.9 pp |
| 2023 | 90.6% | $137.47 Million | $151.66 Million | $14.20 Million | ▼ -6.3 pp |
| 2022 | 96.9% | $227.54 Million | $234.83 Million | $7.29 Million | — |